Synergy CHC Corp.

SNYRQ Healthcare Medical Distribution

Synergy CHC Corp.’s revenue for fiscal 2025 (year ended December 2025) was $30.4 million, down 12.8% from fiscal 2024. In the quarter to March 2026, revenue fell 32.8%, EPS fell 330.0%, free cash flow fell 148.5% and total debt rose 7.08%, each against the same quarter a year earlier.

0.00 0.01 −100.00%
Market cap
$1.3M
P/E
0.0×
Fwd P/E
1.6×
Dividend yield
—
F-score
2/9
Altman Z
−7.00
Beneish M
−7.98
Dividend safety
n/a
Mar '26 Dec '25 Sep '25 Jun '25 Older periods
ROE
76.92% 62.08% (15.44%) (16.93%)

+8 more TTM periods

ROA
(142.75%) (93.11%) 15.71% 20.93%
ROIC
0.00% 0.00% 24.64% 33.86%
Return on Tangible Assets
3,132.84% (693.99%) 15.47% 26.15%
Average Days of Receivables
16.71 38.49 141.44 146.45
Free Cash Flow per Share
(0.34) (0.27) (0.66) (0.51)
Free Cash Flow
(3.81) (2.58) (6.63) (4.56)
Other line items
Cash ROIC
(77,691.84%) (54.41%) (36.93%) (32.23%)
Accounts Receivable Turnover
4.66 4.08 3.16 3.18
Accounts Payable Turnover
2.69 1.74 2.31 1.97
Inventory Turnover
3.35 3.70 4.93 4.67
Average Days of Payables
153.41 231.36 130.41 180.90
Days of Inventory on Hand
128.66 135.36 78.32 86.22
Tax Rate
0.01 0.01 (0.06) 0.01
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
80.46% 72.31% 52.74% 52.16%
Share Based Compensation of Revenue
4.43% 3.66% 3.13% 2.79%
Interest Coverage
(1.61) (1.43) 1.05 1.10
Operating CF/Net income
0.24 0.21 (2.57) (1.41)
Depreciation/Fixed assets
0.00 0.00 0.00 0.00
Capex/Depreciation
0.00 0.00 0.00 0.00
Revenue per Share
2.45 3.12 3.42 3.77
Operating CF per Share
(0.34) (0.27) (0.66) (0.51)
Capex per Share
0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates